BAODING, China, March 15, 2025 – In a major boost to autism treatment and regenerative medicine, top Chinese and German medical experts have joined forces in Baoding. Leading the charge is Prof. Mike Chan, Chairman of the European Wellness Biomedical Group (EWBG) and Senator of the German Federal Association for Economic Development and Foreign Trade (BWA), whose recent visit marks a new chapter in international medical cooperation.
On March 10, Prof. Mike Chan signed a landmark Memorandum of Understanding (MOU) with Baoding Children’s Hospital of Beijing Children’s Hospital—affiliated with Capital Medical University—and Hebei Sanzang Biotechnology Co., Ltd. The agreement establishes an International Joint Laboratory for Pediatric Stem Cell Therapy focused on developing cutting-edge treatments for Autism Spectrum Disorder (ASD) and other neurodevelopmental conditions.
“The untreatable can be treatable,” Prof. Chan declared at the signing ceremony. “Our goal is to transform lives by making advanced stem cell therapies accessible to every child in need.”
The new laboratory, set to be housed in four state-of-the-art research buildings scheduled for completion by June 2025, will serve as a hub for clinical research and training. Its bioregenerative protocols include targeted precursor stem cell therapy to replace damaged neurons, anti-inflammatory and antioxidant treatments to reduce neuroinflammation, and strategies to enhance synaptic plasticity—key steps in improving cognitive and behavioral outcomes in autistic children.
Building on his earlier visit to Baoding in July 2024, when he led a delegation to the 2nd Hospital of Baoding’s Stomatology Department – Oral Specialty Centre, Prof. Chan returned with renewed determination.
“Our discussions last year set the stage for today’s progress,” he said. “Now, with this MOU, we are bridging cultures and technologies in healthcare, ensuring that innovative treatments are developed right here in China.”
In addition to the laboratory project, the delegation visited Baoding’s emerging high-tech medical research district that underscores the city’s ambitions as a global medical innovation center. Here, experts exchanged ideas on future collaborations, including the creation of an international longevity hub in Xi’an. “These partnerships are not just about research—they are about building a future where children receive world-class care without having to leave their homeland,” Prof. Chan added.
Prof. Chan’s commitment to advancing autism care is deeply personal. Diagnosed with autism as a child, he has dedicated his career to pioneering regenerative treatments. His influential books, “Autism Spectrum Disorder: Bioregenerative Medicine with Stem Cell Therapy” and “Autism Spectrum Disorder: Integrative Approach,” have become key resources in the field, guiding clinicians and families on innovative therapeutic strategies.
“I have spent over 40 years abroad developing these technologies,” he explained. “It is time to bring them home so that Chinese patients can benefit from world-class treatment at affordable costs.”
Looking ahead, Prof. Chan is set to be a keynote speaker at the upcoming Autism Health Summit in San Diego, USA, scheduled for April during Autism Awareness Month. He also unveiled plans for the “Children of a Lesser God Foundation,” a charitable initiative aimed at supporting children with autism and other special needs.
With a Germany–China Medical Summit planned for June 2025 and ongoing exchange programs to bolster international collaboration, Baoding is poised to become a beacon of innovation in regenerative medicine and autism research.
“We are creating a new model of healthcare,” Prof. Chan concluded. “This is a turning point that will benefit millions of children worldwide.”
Follow European Wellness on:
Follow European Wellness Academy on:
Follow Prof. Dato’ Sri Dr. Mike Chan on:
Comments are closed.